Chunsheng Li, Ph.D.
Affiliations: | 2005 | Vanderbilt University, Nashville, TN |
Area:
Microbiology Biology, ImmunologyGoogle:
"Chunsheng Li"Parents
Sign in to add mentor| Jack J. Hawiger | grad student | 2005 | Vanderbilt | |
| (MyD88: Central relay station of interleukin 1 signaling pathway.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Huang M, Zhang D, Wu JY, et al. (2020) Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma. Science Translational Medicine. 12 |
| Guo Y, Wang Y, Peng X, et al. (2019) Abstract NT-099: NOVEL ANTIBODY DRUG CONJUGATE (ADC) AND COMPANION DIAGNOSTICS AGAINST CD248+ CANCER Clinical Cancer Research. 25 |
| Yang L, Zhang Y, Shan W, et al. (2017) Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition. Science Translational Medicine. 9 |
| Huang M, Liu T, Ma P, et al. (2016) c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. The Journal of Clinical Investigation |
| Ning C, Xie B, Zhang L, et al. (2016) Infiltrating macrophages induce ERα expression through an IL-17A-mediated epigenetic mechanism to sensitize endometrial cancer cells to estrogen. Cancer Research |
| Yan X, Hu Z, Feng Y, et al. (2015) Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell. 28: 529-40 |
| Santoro SP, Kim S, Motz GT, et al. (2015) T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression. Cancer Immunology Research. 3: 68-84 |
| Hu X, Feng Y, Zhang D, et al. (2014) A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell. 26: 344-57 |
| Li C, Wang J, Hu J, et al. (2014) Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer. Oncotarget. 5: 6994-7012 |
| Matthaiou EI, Barar J, Sandaltzopoulos R, et al. (2014) Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer. International Journal of Nanomedicine. 9: 1855-70 |